can semaglutide cause stroke Does Reduce the Risk of Strokes? What we still don't know

The discovery of the incretin hormone GLP-1 and its subsequent studies led to a better understanding of its role in glycemic control and body weight regulation, as well as its potential use in clinical settings

2022;27(1):e12863

It has gained attention for its potential roles in tissue repair, anti-inflammatory action, and neuroregeneration

For example, Eli Lilly has just reported clinical trial results showing the benefits of its GLP-1, Zepbound (tirzepatide), in reducing the occurrence of sleep apnea events among people with obesity or overweight

Records in one place, one doctor tracking the journey, no upsells between sessions